CTRI/2020/10/028414已完成2 期
Study of Swarna Amalaki as an immunomodulator in Covid-19 Patients
Ministry of AYUSH New Delhi0 个研究点目标入组 65 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 65
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Diagnosed patients of COVID 19with positive RT-PCR test of either sex, between the age group of 20 -70 years
- •2.Patients of COVID 19 receiving standard treatment protocol as prescribed by ICMR/MOHFW, Govt. of India
- •3.Patients giving informed consent
排除标准
- •1.COVID 19 patients requiring ventilator support
- •2.Pregnant ladies and children
- •3.COVID 19 patients with other severe, unstable, uncontrolled co-morbid medical illness such as Diabetes, Hypertension, Cardiac disorders, liver, kidney disorders and lung disorders or other diseases of concern which may put the patient in risk during the study
研究者
相似试验
已完成
3 期
Immunomodulatory effect of Swarna Vachadi Yog on Cell Line and its role in Recurrent Respiratory Infections in childreCTRI/2022/03/041517ational Institute of Ayurveda37
招募中
1 期
Study on Immune Enhancing Effect of Vidhara-Amalaki YogCTRI/2023/07/054802Director of NIA
招募中
3 期
Immunomodulatory effect of an herbal supplement containing Fenugreek, Nigella sativa ?and Sumac in patients with type 2 diabetesIRCT20141209020258N144Arak University of Medical Sciences72
已完成
不适用
Immunomodulatory effects of a proprietary Arabinogalactan extractImmune response to the 23-valent pneumococcal vaccineRespiratoryPneumonia vaccinationISRCTN98817459onza, Inc (USA)50
尚未招募
4 期
Regulating the immunity (Immunomodulatory) in children with wheeze by using homeopathic drug arsenicum albumCTRI/2022/03/041250DrSanthosh Kumar